Yes. Agreed. Owcp taking their time - going thru the protocol normally makes sense but 3 years from now we might be able to buy CBD laced cream at the gas station. World-wide legalization could make CBD's ubiquitous. There are many non-prescription creams already available.
Most people suffering from psoriasis wouldn't bother asking their doctor for a prescription for a cream if they could buy a cheaper version almost anywhere else. The particular formula may not matter to most.
All I'm saying is, this company is in danger of being too slow to market. It's ridiculous that their "safety" study hasn't been announced after a year. I know they don't control it ... but how long then for an actual efficacy study ??
And as for the tablet, I've seen many other American companies bragging about their different approaches to ingestion -gum, water dissolving, infusion, etc. Competition for new methods of ingestion is intense already.
OWCP's delay gives the MMs and their tools like i-glo plenty to write about... further dragging their stock price down, AND that low price may prevent them from cheaply financing operations by the end of the year, and they're going to need $$.
I'm not selling yet... but there are many opportunities elsewhere.
News 
Market Data 
Discover 
AI
